AARP Illinois calls for up-or-down Senate vote on drug price-gouging law
AARP Illinois calls for up-or-down Senate vote on drug price-gouging law … distributor of an essential off-patent or generic drug has violated the act.
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
BRIEF-Adma Biologics Granted US Patent For Treating Respiratory Infections
BRIEF-Adma Biologics Granted US Patent For Treating Respiratory Infections Reuters Full coverage
-
In: PATENT NEWS
Patents: Developing Issues in Post Grant Patent Challenges
Patents: Developing Issues in Post Grant Patent Challenges Lexology Full coverage
-
In: PATENT NEWS
BRIEF-Voip-Pal’s Patent Infringement Lawsuits Vs Twitter, Verizon, AT&T Authorized To Move Forward
BRIEF-Voip-Pal’s Patent Infringement Lawsuits Vs Twitter, Verizon, AT&T Authorized To Move Forward Reuters Voip-Pal.com Inc. Announces Removal of the Stay of Legal Proceedings in its Patent Infringement Lawsuits vs. Twitter … Nasdaq Full coverage
-
In: PATENT NEWS
In win for SAP, US appeals court tosses ‘abstract’ software patent
In win for SAP, US appeals court tosses ‘abstract’ software patent Reuters Full coverage
-
In: PATENT NEWS
Fed. Circ. Says Only 1 District Per State Can Be Patent Venue
Fed. Circ. Says Only 1 District Per State Can Be Patent Venue Law360 Full coverage
-
In: PATENT NEWS
Fed. Circ. Says Only 1 District Per State Can Be Patent Venue
Law360 (May 15, 2018, 8:13 PM EDT) — Rebuking Eastern District of Texas Judge Rodney Gilstrap, the Federal Circuit ruled Tuesday that when …
-
In: PATENT NEWS
Do Patents Really Drive Innovation and Value
Edison might not win given the state of patent law today. The “War of the Currents’ was obviously much more complex than I’m describing it in this post …
-
In: PATENT NEWS
eBook Patent law index download | online | audio id:9tj34wq
eBook Patent law index download | online | audio. Name: Patent law index. Downloads today: 483. Total Downloads: 12483. Format: ebook | djvu | pdf …
-
In: PATENT NEWS
Picking your pharma right: Why alienate US with stent regulations or compulsory licensing?
While the two countries have traditionally sparred on the intellectual property rights (IPR) regime in the pharmaceuticals sector, India must learn the …